SCHEMBL1085140

SCHEMBL1085140

CCOC(=O)/C(C(C)=O)=C(\C)OC

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLO1 Q04760 1/20 0.47
MAPT P10636 3/20 0.42
ALDH1A1 P00352 5/20 0.42
LMNA P02545 1/20 0.42
HSD17B10 Q99714 1/20 0.42
CYP2D6 P10635 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GAA P10253 3/20 0.41
ALOX15 P16050 1/20 0.41
MGAM O43451 1/20 0.41
SI P14410 1/20 0.41
MGAM2 Q2M2H8 1/20 0.41
EGLN1 Q9GZT9 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
TSHR P16473 1/20 0.36
SOAT1 P35610 1/20 0.36
TDP1 Q9NUW8 1/20 0.34
VKORC1 Q9BQB6 1/20 0.34
KDM4E B2RXH2 1/20 0.33
PKM P14618 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1085142 1.00 GLO1 (0.47) GLO1MAPTALDH1A1LMNAHSD17B10
SCHEMBL1085139 1.00 GLO1 (0.47) GLO1MAPTALDH1A1LMNAHSD17B10
SCHEMBL27613337 0.91 ALDH1A1 (0.46) GLO1MAPTALDH1A1LMNAHSD17B10
SCHEMBL3678277 0.86 GLO1 (0.50) GLO1MAPTALDH1A1LMNAHSD17B10
SCHEMBL2357523 0.86 GLO1 (0.50) GLO1MAPTALDH1A1LMNAHSD17B10
SCHEMBL3678281 0.86 GLO1 (0.50) GLO1MAPTALDH1A1LMNAHSD17B10
SCHEMBL28522390 0.85 ALDH1A1 (0.44) GLO1MAPTALDH1A1LMNAHSD17B10
SCHEMBL17827812 0.84 GLO1 (0.56) GLO1MAPTALDH1A1LMNAHSD17B10
SCHEMBL8323786 0.79 GLO1 (0.52) GLO1MAPTALDH1A1LMNAHSD17B10
SCHEMBL14261426 0.79 MAPT (0.37) GLO1MAPTALDH1A1LMNAHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3377473-B1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2024-06-19 EP disclosed
US-20230133817-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS RQX PHARMACEUTICALS INC (US) 2023-05-04 US disclosed
CN-108884058-B Macrocyclic broad spectrum antibiotics 阿奇克斯制药公司 2022-04-29 CN disclosed
US-10947206-B2 cGAS antagonist compounds IMMUNESENSOR THERAPEUTICS, INC. (US) 2021-03-16 US disclosed
US-8153805-B2 Biaryl derivatives HOFFMANN-LA ROCHE INC. (US) 2012-04-10 US disclosed
EP-2205583-A2 N-HETEROCYCLIC BIARYL CARBOXAMIDES AS CCR RECEPTOR ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-07-14 EP disclosed
WO-2009043747-A2 N-HETEROCYCLIC BIARYL CARBOXAMIDES AS CCR RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2009-04-09 WO disclosed
US-20090048238-A1 NOVEL BIARYL DERIVATIVES HOFFMANN-LA ROCHE, INC. 2009-02-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10947206-B2 cGAS antagonist compounds CGAS, STING1, GLS2 GLO1 3461/4885MAPT 4349/4885ALDH1A1 3908/4885
US-20090048238-A1 NOVEL BIARYL DERIVATIVES CCR3, CCRL2, CCR2 GLO1 4167/4885MAPT 4391/4885ALDH1A1 1202/4885
US-20230133817-A1 MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS MRPL21, PEPD, CTSC GLO1 709/4885MAPT 4006/4885ALDH1A1 2364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.